Webinar | June 25, 2020

Challenges Of Drug Development In L-dopa-Naive Subjects With Diagnosis Of Early Parkinson's Disease

Source: Worldwide Clinical Trials

Tomislav Babic, MD, Ph.D., Vice President of Neuroscience at Worldwide Clinical Trials discusses the potential benefit of a delay in initiation for symptomatic treatment with levodopa in early Parkinson's disease patients.

VIEW THE WEBINAR!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader